Clinical Trial

Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures

Study acronym: iVAC
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a multi-center, pragmatic, parallel arm randomized controlled trial (RCT) of 352 patients with high-risk open or closed tibial plateau fracture, high-risk open or closed tibial pilon fracture, or open tibial shaft fracture with incision \>3cm. Eligible participants will be randomized to receive either incisional negative pressure wound therapy (NPWT) or a non-suction standard-of-care wound dressing for their definitive wound management. The primary outcome will be a composite outcome to evaluate clinical status 3 months after randomization.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-03-22; most recent amendment 2026-05-07.
Status change: Not Yet Recruiting → Recruiting 2025-04-29
Trial Details
NCT Number NCT06337292
Lead Sponsor Major Extremity Trauma Research Consortium
Conditions Fracture of Tibia, Wound Heal, Infected Wound, Wound Complication, Wound Dehiscence
Enrollment 352 participants
Start Date 2025-01-01
Primary Completion 2028-09-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-12